Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2418137
Max Phase: Preclinical
Molecular Formula: C22H42N2O6S3
Molecular Weight: 526.79
Molecule Type: Small molecule
Associated Items:
ID: ALA2418137
Max Phase: Preclinical
Molecular Formula: C22H42N2O6S3
Molecular Weight: 526.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)SCCOCCS)N(C)C1
Standard InChI: InChI=1S/C22H42N2O6S3/c1-5-6-14-11-15(24(3)12-14)21(28)23-16(13(2)33-10-8-29-7-9-31)20-18(26)17(25)19(27)22(30-20)32-4/h13-20,22,25-27,31H,5-12H2,1-4H3,(H,23,28)/t13-,14-,15+,16+,17+,18-,19-,20-,22-/m1/s1
Standard InChI Key: RQLNCHYBLIFRLS-AAAIZHQZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 526.79 | Molecular Weight (Monoisotopic): 526.2205 | AlogP: 0.83 | #Rotatable Bonds: 13 |
Polar Surface Area: 111.49 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.97 | CX Basic pKa: 7.80 | CX LogP: 1.24 | CX LogD: 0.69 |
Aromatic Rings: 0 | Heavy Atoms: 33 | QED Weighted: 0.18 | Np Likeness Score: 0.32 |
1. Berkov-Zrihen Y, Green KD, Labby KJ, Feldman M, Garneau-Tsodikova S, Fridman M.. (2013) Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: antimicrobial activity, in vitro inhibition of translation, and drug resistance., 56 (13): [PMID:23786357] [10.1021/jm400707f] |
Source(1):